The FTSE 100 index closed up 0.35 per cent or 26.11 points to 7,589.66 this afternoon, while the FTSE 250 index finished up 0.01 per cent or 2.31 points to 22,655.02. 

UK inflation hit 5.4 per cent in December, with consumer prices now rising at their fastest rate since March 1992, fresh data from the Office for National Statistics shows.

Rising from 5.1 per cent in November, the ONS said consumer price growth in December was driven by food and non-alcoholic beverages, restaurants and hotels, furniture and household goods, and clothing and footwear.

Pub group JD Wetherspoon is set to record a loss for the first half of the fiscal year after the Omicron coronavirus variant led to renewed curbs and kept people from heading out during the festive season.

Wetherspoon’s like-for-like sales fell by 11.7 per cent in the 25 weeks to 16 January, with second-quarter sales hurt by restrictions imposed in December.

Britain’s financial watchdog has proposed a significant strengthening of rules on how high-risk financial products are marketed.

After changes, the Financial Conduct Authority would ensure firms that approve and communicate financial marketing have relevant expertise and understanding of the investments being offered, improve risk warnings on ads and ban incentives to invest.

>If you are using our app or a third-party site click here to read Business Live 

This post first appeared on Dailymail.co.uk

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

UK consumer confidence weaker than during major recessions

Monthly look finds deepening pessimism about personal finances and prospects for the…

Games Workshop declares another dividend reward after continued strong trading

Shareholders in Games Workshop are set for yet more good fortune after…

I’ve found ‘perfect alternative to central heating’ in Russell Hobbs gadget – it costs less than £30 & everyone loves it

A WOMAN has found the “perfect alternative to central heating” in a…

AstraZeneca reaches £351m settlement over heartburn drug claims

AstraZeneca will pay a $425million (£351million) settlement to bring an end to claims…